PBYI- Puma Biotechnology, Inc.

Name: Puma Biotechnology, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Puma Biotechnology, Inc. (PBYI) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. PBYI is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Auerbach Alan H	227.5K	$1.74M	-
Other	Hunt Douglas M	70.3K	$538.7K	-
CFO	Nougues Maximo F	66.5K	$509.7K	-
Dir	Miller Michael Patrick	54.0K	$413.6K	-
Dir	Cesano Alessandra	41.9K	$320.6K	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 3, 2022	Hunt Douglas M62	See Remarks	Sell	3,707	$3.21	$11,889.83	-5.7%	-0.3%	+29.5%
Jan 3, 2022	Auerbach Alan H62	President And CEO	Sell	22,875	$3.19	$72,923.21	-0.5%	-0.3%	+29.5%
Jan 3, 2022	Nougues Maximo F61	Chief Financial Officer	Sell	7,484	$3.19	$23,870.97	-11.1%	-0.3%	+29.5%
Dec 2, 2021	Hunt Douglas M62	See Remarks	Sell	441	$2.90	$1,278.90	-0.7%	-26.2%	+47.8%
Dec 2, 2021	Wong Alvin F56	Chief Scientific Officer	Sell	1,131	$2.91	$3,294.38	-6.2%	-26.2%	+47.8%
Dec 2, 2021	Nougues Maximo F61	Chief Financial Officer	Sell	162	$2.95	$477.90	-0.2%	-26.2%	+47.8%
Dec 2, 2021	Auerbach Alan H62	President And CEO	Sell	1,837	$2.90	$5,327.30	-	-26.2%	+47.8%
Nov 2, 2021	Nougues Maximo F61	Chief Financial Officer	Sell	156	$5.67	$884.68	-0.2%	-59.9%	-64.8%
Nov 2, 2021	Hunt Douglas M62	See Remarks	Sell	427	$5.64	$2,408.71	-0.7%	-59.9%	-64.8%
Nov 2, 2021	Auerbach Alan H62	President And CEO	Sell	1,795	$5.63	$10,111.95	-	-59.9%	-64.8%

← PrevPage 11Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC